GB1330878A — Ketamine resolution
Assigned to Bristol Myers Co · Expires 1973-09-19 · 53y expired
What this patent protects
1330878 Ketamine resolution BRISTOL MYERS CO 18 Dec 1970 [19 Dec 1969] 60173/70 Heading C2C Ketamine is resolved with tartaric acid and the isomers may be converted to salts. These compounds are anaesthetics and anticonvulsants, and may be administered in the form of pharmaceutic…
USPTO Abstract
1330878 Ketamine resolution BRISTOL MYERS CO 18 Dec 1970 [19 Dec 1969] 60173/70 Heading C2C Ketamine is resolved with tartaric acid and the isomers may be converted to salts. These compounds are anaesthetics and anticonvulsants, and may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.